Headline News about Incyte Corp
Anemia Advantage For GSK's Blood Cancer Therapy Could Influence Market Share Despite Incyte's Jakafi Comparison
September 18, 2023
Via Benzinga
Exposures
Product Safety
Analyst Ratings for Incyte
August 02, 2023
Via Benzinga
Incyte's Earnings Outlook
July 31, 2023
Via Benzinga
Earnings Outlook For Incyte
May 01, 2023
Via Benzinga
Via Benzinga
Via Benzinga
Ominous Death Cross Forms On Incyte's Chart
April 13, 2023
Via Benzinga
What 13 Analyst Ratings Have To Say About Incyte
March 28, 2023
Via Benzinga
Via Talk Markets
Via Benzinga
Via Benzinga
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|